Previous 10 | Next 10 |
BioLife Solutions Announces First Quarter 2021 Financial Results Achieves record quarterly revenue of $16.8 million, a 39% increase over the prior year and 14% increase over the prior quarter Full year revenue guidance raised to $106 to $115 million reflecting confidence in ...
BioLife Solutions to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021 PR Newswire BOTHELL, Wash. , May 6, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a ...
BioLife Solutions (BLFS) has closed the previously announced acquisition of Stirling Ultracold, a privately held manufacturer of ultra-low temperature ("ULT") mechanical freezers.The company also provided guidance for Stirling's 2021 post-closing revenue contribution to be $35M to $37M, ...
BioLife Solutions Announces Closing of Stirling Ultracold Acquisition and Expanded Partnership with Leading Global Biopharma CDMO Stirling Named Preferred Provider of Ultra Low Temperature (ULT) Storage Across Multiple Business Units Customer Uses BioLife's Entire Bioproduct...
BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer Product Fills Critical Cold Chain Need to Enable High Volume Production of Allogeneic Cell Therapies PR Newswire BOTHELL, Wash. , A...
BioLife Solutions Appoints Two New Independent Board Directors Amy DuRoss, CEO at Vineti and Rachel Ellingson, Chief Strategy Officer at Zimmer Biomet PR Newswire BOTHELL, Wash. , April 6, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: B...
The following slide deck was published by BioLife Solutions, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: BioLife Solutions, Inc. 2020 Q4 - Results - Earnings Call Presentation
Ionis Pharmaceuticals (IONS) is extending the post-market loss with a ~19.6% decline today in the before hours in reaction to the setback it has suffered for tominersen in two of the studies for Huntington's disease (“HD”) conducted in partnership with Roche (OTCQX:RHH...
Image source: The Motley Fool. Biolife Solutions Inc (NASDAQ: BLFS) Q4 2020 Earnings Call Mar 22, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Biolife Solutions Inc (BLFS) Q4 2020 Earnings Call Transcript
BioLife Solutions, Inc. (BLFS) Q4 2020 Earnings Conference Call March 22, 2021 16:30 ET Company Participants Rod de Greef - Chief Financial Officer Mike Rice - Chief Executive Officer Dusty Tenney - President and Chief Operating Officer Conference Call Participants Paul Knight - KeyBanc Chris...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...